Advasa Completes a Nasdaq Direct Listing: What the 8-K Says
A Nasdaq direct listing puts a company’s existing shares on the exchange for trading without the company running an underwritten IPO, and Advasa Holdings, Inc. reported on August 25, 2026 that it has completed one.
The company, a Delaware holding company that runs its business through a Tokyo-based subsidiary, filed a Form 8-K under Item 8.01 (Other Events) with a press release as Exhibit 99.1. The shares trade on the Nasdaq Global Market under the ticker ADBT.
What happened
According to the press release, Advasa’s registration statement on Form S-1 (File No. 333-292013) was declared effective by the SEC on August 11, 2026, and the common stock was approved for listing on the Nasdaq Global Market. The company announced the completed listing two weeks later. It also says it filed its Form 10-Q for the quarter ended June 30, 2026, on August 12, the day after effectiveness.
Advasa describes itself as a fintech payment holding company. Its operating subsidiary, ADVASA Co., Ltd., runs an earned wage access platform called FUKUPE, which lets employees draw wages they have already earned in real time. The company says a global patent strategy has given it an intellectual property foundation in markets including Japan, the United States, South Korea and Singapore, and it plans to expand to markets that include Indonesia and the United Arab Emirates.
Chief Executive Officer Grady Ryther is quoted in the release thanking employees, partners, advisors and shareholders. WestPark Capital, Inc. acted as financial advisor and Anthony, Linder & Cacomanolis, PLLC as securities counsel. The release adds that trading is expected to be accessible through several Japanese brokerages, among them Monex, Moomoo Securities Japan, Rakuten Securities, SBI Securities and Webull Securities Japan, subject to each firm’s timelines and restrictions. The filing cover page marks Advasa as an emerging growth company.
The release does not state an opening price, a reference price or a number of shares registered.
How it works
In a traditional IPO, a company sells new shares through underwriters and raises capital at a price set before trading starts. In a direct listing, the company registers shares with the SEC, usually on Form S-1, so that existing holders can sell them once the stock is listed. Trading opens without a firm-commitment underwriting, and price is set by buyers and sellers in the exchange’s opening process.
The route still involves substantial paperwork. The company files a registration statement, responds to SEC staff comments, receives a notice of effectiveness and obtains exchange approval. Advasa’s release follows that sequence and says the listing was made only through a prospectus that forms part of the effective registration statement, available free of charge on EDGAR.
The structure appeals to companies that want a public trading market and a base of existing holders without the dilution and fees of an underwritten sale. It also carries trade-offs, including no built-in group of underwriters to support early trading.
Key terms
- Form S-1: the general registration statement for securities offered or resold to the public.
- Effectiveness: the point at which the SEC allows the registration statement to be used.
- Item 8.01: the 8-K item for events a company chooses to report that fit no other item.
- Emerging growth company: an issuer that qualifies for scaled disclosure and other accommodations under the JOBS Act.
- Earned wage access: a service that lets workers receive pay they have already earned before the regular payday.
FAQ
Did Advasa raise money? The filing does not describe any proceeds.
Where can the prospectus be found? On the SEC’s EDGAR system under File No. 333-292013.
Is a direct listing the same as Regulation A+? No. Regulation A+ is an exemption that lets a company offer securities to the public with a lighter-weight offering statement on Form 1-A. A direct listing here proceeds under a full Form S-1.
This article summarizes a public filing and is not investment advice.
Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.


